Co-Diagnostics saw the highest growth of 0.99% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Co-Diagnostics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Co-Diagnostics has been focused on protecting inventions in European Patent Office(EPO) with one publication in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings with nearly 50% of filings. The European Patent Office(EPO), United States(US), and Spain(ES) patent Office are among the top ten patent offices where Co-Diagnostics is filings its patents. Among the top granted patent authorities, Co-Diagnostics has 100% of its grants in Spain(ES).
Roche could be the strongest competitor for Co-Diagnostics
Patents related to rare diseases and Covid-19 lead Co-Diagnostics's portfolio
Co-Diagnostics has the highest number of patents in rare diseases followed by, Covid-19. For rare diseases, nearly 50% of patents were filed and no patents were granted in Q2 2024.
For comprehensive analysis of Co-Diagnostics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
